Recent advances in therapeutic gene-editing technologies.

Area of Science:

• Biomedical Research
• Gene Therapy
• Molecular Biology

Background:

• CRISPR gene editing has rapidly evolved, leading to precise nucleotide modification tools.
• New CRISPR-based systems and alternatives like mobile genetic elements (MGEs) and epigenetic editors are emerging.
• These innovations overcome limitations of earlier gene editing techniques, such as double-strand breaks (DSBs).

Purpose of the Study:

• To review recent advancements in genetic and epigenetic editing tools.
• To explore preclinical innovations in gene editing for therapeutic development.
• To highlight the potential of these tools for next-generation gene therapy.

Main Methods:

• Review of recent scientific literature on gene editing technologies.
• Analysis of CRISPR-based systems, including base and prime editors.
• Exploration of alternative gene editing strategies like MGEs and epigenetic editors.

Main Results:

• CRISPR technology has advanced to base and prime editors, allowing precise edits without double-strand breaks.
• CRISPR fusion systems and other tools expand capabilities for editing larger DNA sequences.
• Mobile genetic elements and epigenetic editors offer efficient alternatives for large insertions and stable gene manipulation.

Conclusions:

• Recent gene editing tool developments, including CRISPR iterations and novel alternatives, are revolutionizing biomedical research.
• These advanced tools expand therapeutic possibilities and pave the way for next-generation gene therapies.
• Preclinical innovations in gene editing are poised to significantly advance the field of gene therapy.